期刊文献+

Man_8GlcNAc_2糖基化的酿酒酵母菌株的构建 被引量:1

Construction of the Man_8GlcNAc_2 glycosylation Saccharomyces cerevisiae mutant strain
下载PDF
导出
摘要 酿酒酵母糖蛋白的N-糖基化经过高尔基体的修饰后形成聚合度约150-200的甘露寡糖,高尔基体N-糖基化的糖基转移酶Mnn1p和Och1p在甘露寡糖的形成过程中起关键作用。通过同源重组置换敲除了酵母中的MNN1和OCH1基因阻断高尔基体N-糖基化修饰,分离纯化了mnn1 och1突变株中的N-糖蛋白,糖酰胺酶PNGaseF酶解释放的N-糖链经过2-氨基吡啶衍生后,利用HPLC和MALDITOF/MS结合的方法分析了突变株糖蛋白上的N-糖链。结果显示mnn1 och1突变株中的糖蛋白的N-糖链为结构单一的糖链,分子量为1794.66,推测为Man8GlcNAc2。 In Saccharomyces cerevisiae,protein glycosylation passed two different N-linked modification pathways after the export of predominantly Man8GlcNAc2-containing glycoproteins from ER to the Golgi. The core oligosaccharide undergoes maturation in the Golgi resulting in a Man 8-13 GlcNAc2 structure. Alternatively,core structures may be hypermannosylated with up to 200 mannose residues composing of a backbone of α1,6-mannosyl residues with branched α1,2-and α1,3-mannosyl side chains. Mnn1p and Och1p play an important role in this process. The null disruption of MNN1,OCH1 was replaced by the S. cerevisiae URA3,HIS3,respectively. To characterize the N-glycosylation in the mnn1 och1 mutant,mannoproteins were obtained by hot citrate buffer extraction after the mnn1 och1 cells were crumbled. The extracted mannoprotein was precipitated by ethanol,and further purified by concanavalin A-sepharose 4B. The N-oligomannose saccharides were released from mannoprotein by PNGase F digestion,and then peptides and detergents were removed by passage through ion exchange columns. For desalting,glycans were applied to porous graphitic-carbon cartridge. 2-aminopyridine pyridylaminated sugars were profiled and purified by size fractionation HPLC with Shim-pack clc-NH_2 column,and result showed dominantly a single peak. MALDI TOF/MS analysis ofthis peak revealed that its molecular weight was 1796.5Da,which corresponds to the calculated mass of Man_8GlcNAc_2-PA. These results indicated that disruptions of MNN1 and OCH1 eliminated the hypermannosylation of the N-linked glycans,and glycoproteins were glycosylated with a single core type glycan,Man8GlcNAc2,in the mnn1 och1 mutant.
出处 《微生物学报》 CAS CSCD 北大核心 2007年第5期785-789,共5页 Acta Microbiologica Sinica
基金 国家自然科学基金(30470399) 山东省中青年科学家奖励基金(2006BS02011)~~
关键词 酿酒酵母 糖基化 甘露糖蛋白 甘露糖基转移酶 Saccharomyces cerevisiae Glycosylation Mannoprotein Mannosyltransferase
  • 相关文献

参考文献16

  • 1Chin JW, Cropp TA, Anderson JC, et al. An expanded eukaryotie genetic code. Science, 2003,301 : 964 - 967.
  • 2Wacker M, Linton D, Hitchen PG, et al. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science ,2002,298: 1790- 1793.
  • 3Choi BK, Bobrowicz P, Davidson RC, et al. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci USA ,2003,100: 5022 - 5027.
  • 4Macauley-Patrick S, Fazenda ML, McNeil B, et al. Heterologous protein production using the Pichia pastoris expression system. Yeast, 2005,22 : 249 - 270.
  • 5Joseph S,David WR.分子克隆实验指南.第三版.黄培堂,王嘉玺,朱厚础,等译.北京:科学出版社,2002.
  • 6Davidson RC, Blankenship JR, Kraus PR, et al. A PCR-based strategy, to generate integrative targeting alleles with large regions of homology. Microbiology, 2002,148 : 2607 - 2615.
  • 7Peat S, Whelan WJ. Polysaccharides of baker' s yeast. IV. Mannan. J Chem Soc, 1961,29 - 34.
  • 8Verostek MF, Atkinson PH,Trimble RB. Structure of Saccharomyces cerevisiae alg3, sec18 mutant oligosaccharides. J Biol Chem, 1991, 266:5547 - 5551.
  • 9Grubenmann CE, Frank CG, Hulsmeier AJ, et al. Deficiency of the first mannosylation step in the N-glyeosylation pathway causes congenital disorder of glycosylation type lk. Hum Mol Genet, 2004, 13 : 535 - 542.
  • 10Fan JQ, Huynh LH, Lee YC. Purification of 2-aminopyridine derivatives of oligosaeeharides and related compounds by cationexchange chromatography. Anal Biochem, 1995,232: 65 - 68.

共引文献1

同被引文献16

  • 1Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology, 1993, 3(2): 97-130.
  • 2Rudd PM, Tim Elliott, Peter Cresswe11, lan A. Wilson, Raymond A. Dwek. Glycosylation and the Immune System. Science, 2001, 291(5512): 2370-2376.
  • 3Sinclair AM, Elliott S. Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins. Journal of Pharmaceutical Sciences, 2005, 94 ( 8 ) : 1626- 1635.
  • 4Sethuraman N, Stadheim TA. Challenges in therapeutic glycoprotein production. Current Opinion in Biotechnology, 2006, 17 ( 4 ) : 341-346.
  • 5Hamilton SR, Gerngross TU. Glycosylation engineering in yeast: the advent of fully humanized yeast. Current Opinion in Biotechnology, 2007, 18 (5) : 387-392.
  • 6Lizak C, Fan YY, Weber TC, Aebi M. N-Linked Glycosylation of Antibody Fragments in Escherichia coli. Bioconjugate Chemistry, 2011, 22 ( 3 ) : 488-496.
  • 7De Pourcq K, De Schutter K, Callewaert N. Engineering of glycosylation in yeast and other fungi: current state and perspectives. Applied Microbiology and Biotechnology, 2010, 87(5) : 1617-1631.
  • 8Wildt S, Gerngross TU. The humanization of N- glycosylation pathways in yeast. Nature Reviews Microbiology, 2005, 3 ( 2 ) : 119-128.
  • 9Graham TR, Emr SD. Compartmental organization of Golgi-specific protein modification and vacuolar protein sorting events defined in a yeast secl8 (NSF) mutant. Journal of Cell Biology, 1991, 114(2) : 207-218.
  • 10Yip CL, Welch SK, Klebl F, Gilbert T, Seidel P, Grant FJ, OHara PJ, MacKay VL. Cloning and analysis of the Saccharomyces cerevisiae MNN9 and MNN1 genes required for complex glycosylation of secreted proteins. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91 (7) : 2723-2727.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部